Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat

Marie Louise G. Wadenberg, Dina Manetti, Maria Novella Romanelli, Hugo R. Arias

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Schizophrenic (SCH) patients show cognitive impairment in attentional performance. Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors (nAChRs) such as the Alzheimer's drug galantamine (GAL) and PAM-2 are documented to have pro-cognitive properties. However, it is not well established if these properties would be lost, or may hamper antipsychotic efficacy, when given as an adjunct to an antipsychotic which is needed for managing psychotic symptoms. Using adult male Wistar rats, we here investigated the effects of: a) GAL, alone or co-administered with the antipsychotic risperidone (RISP), on acute phencyclidine (PCP)-induced deficits in the attentional set-shifting (ASST) test; b) PAM-2, alone and co-administered with RISP, in the conditioned avoidance response (CAR) test for antipsychotic activity. Acute PCP produced selective and significant SCH-like impairment in extra dimensional shift (EDS) performance, which was completely reversed by GAL. The ability of GAL to reverse PCP-induced EDS impairment was not prevented when co-administered with RISP, suggesting that the combination of GAL and low doses of RISP may be used to improve the cognitive impairment in SCH. Pretreatment with methyllycaconitine (MLA), a selective α7 nAChR antagonist, completely prevented the reversal elicited by GAL, supporting the concept that α7 nAChRs are involved in this process. On the other hand, PAM-2 alone had no effects on CAR, but enhanced, although not significantly, the antipsychotic-like effect of RISP when administered together. In conclusion, α7 PAMs, in addition to alleviate the cognitive impairments observed in SCH patients, may enhance the antipsychotic efficacy of atypical antipsychotics.

Original languageEnglish
Pages (from-to)129-134
Number of pages6
JournalBehavioural Brain Research
Volume333
DOIs
StatePublished - 30 Aug 2017
Externally publishedYes

Fingerprint

Galantamine
Nicotinic Receptors
Cognition
Antipsychotic Agents
Risperidone
Phencyclidine
Aptitude
Wistar Rats
Pharmaceutical Preparations
Cognitive Dysfunction

Keywords

  • Attentional set-shifting
  • Conditioned avoidance response
  • Risperidone
  • Schizophrenia
  • α7 Nicotinic acetylcholine receptor positive allosteric modulators

Cite this

Wadenberg, Marie Louise G. ; Manetti, Dina ; Romanelli, Maria Novella ; Arias, Hugo R. / Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat. In: Behavioural Brain Research. 2017 ; Vol. 333. pp. 129-134.
@article{f82ff919475a44aca4c8ed1a19192fbc,
title = "Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat",
abstract = "Schizophrenic (SCH) patients show cognitive impairment in attentional performance. Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors (nAChRs) such as the Alzheimer's drug galantamine (GAL) and PAM-2 are documented to have pro-cognitive properties. However, it is not well established if these properties would be lost, or may hamper antipsychotic efficacy, when given as an adjunct to an antipsychotic which is needed for managing psychotic symptoms. Using adult male Wistar rats, we here investigated the effects of: a) GAL, alone or co-administered with the antipsychotic risperidone (RISP), on acute phencyclidine (PCP)-induced deficits in the attentional set-shifting (ASST) test; b) PAM-2, alone and co-administered with RISP, in the conditioned avoidance response (CAR) test for antipsychotic activity. Acute PCP produced selective and significant SCH-like impairment in extra dimensional shift (EDS) performance, which was completely reversed by GAL. The ability of GAL to reverse PCP-induced EDS impairment was not prevented when co-administered with RISP, suggesting that the combination of GAL and low doses of RISP may be used to improve the cognitive impairment in SCH. Pretreatment with methyllycaconitine (MLA), a selective α7 nAChR antagonist, completely prevented the reversal elicited by GAL, supporting the concept that α7 nAChRs are involved in this process. On the other hand, PAM-2 alone had no effects on CAR, but enhanced, although not significantly, the antipsychotic-like effect of RISP when administered together. In conclusion, α7 PAMs, in addition to alleviate the cognitive impairments observed in SCH patients, may enhance the antipsychotic efficacy of atypical antipsychotics.",
keywords = "Attentional set-shifting, Conditioned avoidance response, Risperidone, Schizophrenia, α7 Nicotinic acetylcholine receptor positive allosteric modulators",
author = "Wadenberg, {Marie Louise G.} and Dina Manetti and Romanelli, {Maria Novella} and Arias, {Hugo R.}",
year = "2017",
month = "8",
day = "30",
doi = "10.1016/j.bbr.2017.07.001",
language = "English",
volume = "333",
pages = "129--134",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat. / Wadenberg, Marie Louise G.; Manetti, Dina; Romanelli, Maria Novella; Arias, Hugo R.

In: Behavioural Brain Research, Vol. 333, 30.08.2017, p. 129-134.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Significance of the nicotinic alpha7 receptor in cognition and antipsychotic-like behavior in the rat

AU - Wadenberg, Marie Louise G.

AU - Manetti, Dina

AU - Romanelli, Maria Novella

AU - Arias, Hugo R.

PY - 2017/8/30

Y1 - 2017/8/30

N2 - Schizophrenic (SCH) patients show cognitive impairment in attentional performance. Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors (nAChRs) such as the Alzheimer's drug galantamine (GAL) and PAM-2 are documented to have pro-cognitive properties. However, it is not well established if these properties would be lost, or may hamper antipsychotic efficacy, when given as an adjunct to an antipsychotic which is needed for managing psychotic symptoms. Using adult male Wistar rats, we here investigated the effects of: a) GAL, alone or co-administered with the antipsychotic risperidone (RISP), on acute phencyclidine (PCP)-induced deficits in the attentional set-shifting (ASST) test; b) PAM-2, alone and co-administered with RISP, in the conditioned avoidance response (CAR) test for antipsychotic activity. Acute PCP produced selective and significant SCH-like impairment in extra dimensional shift (EDS) performance, which was completely reversed by GAL. The ability of GAL to reverse PCP-induced EDS impairment was not prevented when co-administered with RISP, suggesting that the combination of GAL and low doses of RISP may be used to improve the cognitive impairment in SCH. Pretreatment with methyllycaconitine (MLA), a selective α7 nAChR antagonist, completely prevented the reversal elicited by GAL, supporting the concept that α7 nAChRs are involved in this process. On the other hand, PAM-2 alone had no effects on CAR, but enhanced, although not significantly, the antipsychotic-like effect of RISP when administered together. In conclusion, α7 PAMs, in addition to alleviate the cognitive impairments observed in SCH patients, may enhance the antipsychotic efficacy of atypical antipsychotics.

AB - Schizophrenic (SCH) patients show cognitive impairment in attentional performance. Positive allosteric modulators (PAMs) of α7 nicotinic acetylcholine receptors (nAChRs) such as the Alzheimer's drug galantamine (GAL) and PAM-2 are documented to have pro-cognitive properties. However, it is not well established if these properties would be lost, or may hamper antipsychotic efficacy, when given as an adjunct to an antipsychotic which is needed for managing psychotic symptoms. Using adult male Wistar rats, we here investigated the effects of: a) GAL, alone or co-administered with the antipsychotic risperidone (RISP), on acute phencyclidine (PCP)-induced deficits in the attentional set-shifting (ASST) test; b) PAM-2, alone and co-administered with RISP, in the conditioned avoidance response (CAR) test for antipsychotic activity. Acute PCP produced selective and significant SCH-like impairment in extra dimensional shift (EDS) performance, which was completely reversed by GAL. The ability of GAL to reverse PCP-induced EDS impairment was not prevented when co-administered with RISP, suggesting that the combination of GAL and low doses of RISP may be used to improve the cognitive impairment in SCH. Pretreatment with methyllycaconitine (MLA), a selective α7 nAChR antagonist, completely prevented the reversal elicited by GAL, supporting the concept that α7 nAChRs are involved in this process. On the other hand, PAM-2 alone had no effects on CAR, but enhanced, although not significantly, the antipsychotic-like effect of RISP when administered together. In conclusion, α7 PAMs, in addition to alleviate the cognitive impairments observed in SCH patients, may enhance the antipsychotic efficacy of atypical antipsychotics.

KW - Attentional set-shifting

KW - Conditioned avoidance response

KW - Risperidone

KW - Schizophrenia

KW - α7 Nicotinic acetylcholine receptor positive allosteric modulators

UR - http://www.scopus.com/inward/record.url?scp=85021792351&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2017.07.001

DO - 10.1016/j.bbr.2017.07.001

M3 - Article

C2 - 28684359

AN - SCOPUS:85021792351

VL - 333

SP - 129

EP - 134

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -